[1]
“Change in serum lipid profiles and glucose subsequent to changing from stavudine/lamivudine to zidovudine/lamivudine in non-nucleoside reverse transcriptase inhibitors based hostile to retroviral regimens in Southern Ethiopia ”, AJAHR, vol. 3, no. 1, pp. 1–9, Feb. 2015, Accessed: Oct. 28, 2026. [Online]. Available: https://kevinpage.org/index.php/AJAHR/article/view/16